Sonendo® Announces Next Generation GentleWave® G4 System | Company
LAGUNA HILLS, Calif.–(BUSINESS WIRE)–October 18, 2022–
Sonendo, Inc. (NYSE:SONX), a leading dental technology company and developer of the GentleWave® System, today announced the launch of the GentleWave G4 System, the next generation of its innovative technology platform designed to treat the tooth decay. With Sonendo’s patented technology at its core, the GentleWave G4 system is designed for an optimized physician and patient experience with a refined and simplified workflow – while delivering the enhanced level of cleaning that is only available with GentleWave technology. Broad-spectrum acoustic energy and advanced fluid dynamics deliver advanced disinfection to penetrate even the most complex tomies, resulting in a predictable, superior level of cleansing and improved healing time.
Since its inception, the GentleWave procedure has redefined the standard of root canal treatment with a minimally invasive process that preserves tooth structure and promotes early healing. According to a recent clinical trial, 99.5% of patients experienced minimal or no pain during the GentleWave procedure with the addition of CleanFlow™ technology.
Hot on the heels of the launch of CleanFlow technology in April this year, the GentleWave G4 system marks Sonendo’s latest innovation and demonstrates the company’s continued investment in dental technology and the specialty of endodontics.
“The GentleWave G4 system underscores our commitment to world-class innovation. Our new console has a modern look, is highly efficient and designed for the future of endodontics by being software-upgradable and ready to accept future technical innovations. of Sonendo. This is a direct result of listening to the needs of our practitioners and satisfying them through product innovation,” said Bjarne Bergheim, President and CEO of Sonendo. “With a mission to save teeth and improving lives, we are proud to introduce this next-generation GentleWave system to the market – a testament to our commitment to improving patient care and practice workflow. We are truly transforming the way root canals are performed.”
The GentleWave G4 system was created with future software adaptations and feature evolution in mind. An intuitive, user-friendly interface provides step-by-step guidance to practitioners and auditory cues that enhance procedural awareness, reducing the need to look away from the patient during treatment. Battery backup and large capacity fluid reservoirs reduce downtime between treatments and allow for up to six procedures before refilling fluids. The system also enables multi-operative connectivity, which means physicians can monitor multiple systems in their practice, improving workflow efficiency.
“Since adopting the GentleWave System, I have seen increased productivity in my practice and more successful root canal procedures,” said Rick Simcock, DDS, Bellingham, Washington-based endodontist and user of the GentleWave System. “I’m confident this next iteration will bring even more efficiency, as the increased fluid capacity and new battery backup dramatically reduce system prep time between procedures. The GentleWave G4 system is further proof of the Sonendo’s investment in my practice and the broader specialty.”
The GentleWave G4 system will be showcased at EndoCon ® , Sonendo’s second annual endodontic innovation conference, taking place in San Diego October 20-22.
For more information on Sonendo and the GentleWave G4 system, or to express your interest, please visit www.gentlewave.com/doctor/G4. To find a GentleWave physician in your area, please visit www.gentlewave.com.
Sonendo is a commercial-stage medical technology company focused on protecting teeth against tooth decay, the most prevalent chronic disease in the world. Sonendo has developed and manufactured the GentleWave® System, an innovative technology platform designed to treat tooth decay by cleaning and disinfecting microscopic spaces inside teeth without having to remove tooth structure. The system uses a proprietary mechanism of action, which combines procedural fluid optimization, broad-spectrum acoustic energy, and advanced fluid dynamics, to debride and disinfect deep regions of the complex root canal system in one procedure. less invasive that preserves the structure of the tooth. Clinical advantages of the GentleWave system over conventional root canal treatment methods include improved clinical outcomes, such as superior cleaning that is independent of root canal complexity and tooth anatomy, healing rates high and rapid and minimal or no postoperative pain. . Additionally, the GentleWave system can improve dental practice workflow and economy and provides patients with an effective, less invasive and less painful alternative to traditional root canal therapy.
Sonendo is also the parent company of TDO® Software, Inc., the developer of widely used endodontic practice management software solutions designed to simplify practice workflow. TDO software integrates practice management, imaging, referral reporting and CBCT imaging, and offers integrated communication with the GentleWave system.
For more information on Sonendo and the GentleWave system, please visit www.gentlewave.com/doctor/G4. To find a GentleWave physician in your area, please visit www.gentlewave.com.
This press release contains “forward-looking statements” based on Sonendo’s current expectations, forecasts and beliefs, including statements related to the general release of the GentleWave G4 system. These forward-looking statements are subject to inherent uncertainties, risks and assumptions that are difficult to predict. Actual results could differ materially due to a number of factors, including continued uncertainty about the impact of the COVID-19 pandemic, as well as the impact of the COVID recovery, on its business. These and other risks and uncertainties include those described in more detail in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2021 filed with the Securities and Exchange Commission (the “SEC ) on March 23, 2022, Quarterly Reports on Form 10-Q for the quarters ended March 31, 2022 and June 30, 2022 filed with the SEC on May 10, 2022 and August 10, 2022, respectively, under the sections captioned “ Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations”, as well as any reports Sonendo may file with the SEC in the future. The forward-looking statements contained in this announcement are based on information available to Sonendo as of the date hereof. Sonendo assumes no obligation to update this information, except as required by applicable law. These forward-looking statements should not be taken to represent the views of Sonendo as of any date subsequent to the date of this press release and should not be relied upon as predictions of future events. In light of the foregoing, investors are cautioned not to rely on any forward-looking statements in drawing any conclusion or making an investment decision regarding Sonendo’s securities. GENTLWAVE and ENDOCON are registered trademarks of Sonendo, Inc.
See the source version on businesswire.com: https://www.businesswire.com/news/home/20221018005231/en/
CONTACT: Sarah Gallagher
(224) 406-4709 Greg Chodaczek
KEYWORD: CALIFORNIA UNITED STATES NORTH AMERICA
INDUSTRY KEYWORD: TECHNOLOGY MEDICAL DEVICES DENTAL OTHER HEALTH TECH TECHNOLOGY SOFTWARE HARDWARE CARE MANAGEMENT GENERAL HEALTH HEALTH
SOURCE: Sonendo, Inc.
Copyright BusinessWire 2022.
PUBLISHED: 10/18/2022 07:00/DISC: 10/18/2022 07:02